4
Changes in Ownership
CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-18-003392
Options or other derivatives
- SVP Clinical Development, CMO acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Thackray Helen M. · SVP Clinical Development, CMO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-01-10 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +75,000 | 75,000 | D |
Loading xslF345X03/doc4.xml…